Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epileptic encephalopathy.

O Dulac1

  • 1Service de Neuropediatrie, Hôpital Saint Vincent de Paul, 82 Avenue Denfert-Richfereau, 75674 Paris Cedex, France.

Epilepsia
|August 25, 2001
PubMed
Summary
This summary is machine-generated.

Epileptic encephalopathies cause neurological decline due to seizures. Specific treatments exist for syndromes like severe myoclonic epilepsy in infancy and infantile spasms, but some drugs must be avoided.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcome of childhood-onset epilepsy from adolescence to adulthood: Transition issues.

Epilepsy & behavior : E&B·2017
Same author

Dynamic changes of depolarizing GABA in a computational model of epileptogenic brain: Insight for Dravet syndrome.

Experimental neurology·2016
Same author

Temporal lobe epilepsy in infants and children.

Revue neurologique·2015
Same author

Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model.

Nature communications·2014
Same author

Epileptic syndromes in infancy and childhood: recent advances.

Epilepsia·2012
Same author

A prospective open-labeled trial with levetiracetam in pediatric epilepsy syndromes: continuous spikes and waves during sleep is definitely a target.

Seizure·2011
Same journal

Semiology of functional/dissociative seizures in idiopathic generalized epilepsy: An inpatient video-electroencephalographic study.

Epilepsia·2026
Same journal

Perineuronal net abnormalities in epileptic human tissue.

Epilepsia·2026
Same journal

Cortical stimulation reveals effective disconnection of the epileptogenic network at seizure onset.

Epilepsia·2026
Same journal

Anterior cingulate cortex neuron subtypes differentially regulate seizures.

Epilepsia·2026
Same journal

Ultrafast oscillations in the human brain and their functional significance.

Epilepsia·2026
Same journal

Magnetoencephalographic source imaging improves localization of the epileptogenic zone in multimodal imaging evaluation.

Epilepsia·2026
See all related articles

Area of Science:

  • Neurology
  • Epileptology
  • Pediatric Neurology

Background:

  • Epileptic encephalopathies are characterized by neurological deterioration stemming from epileptic activity.
  • This can manifest as frequent, severe seizures or continuous interictal activity.
  • Syndromes include severe myoclonic epilepsy in infancy (SMEN), migrating partial epilepsy, Ohtahara syndrome, infantile spasms (IS), Lennox-Gastaut syndrome (LGS), and continuous spike-waves in slow sleep (CSWS).

Purpose of the Study:

  • To review the diverse range of epileptic encephalopathies.
  • To outline the distinct clinical presentations and diagnostic features of these syndromes.
  • To discuss current and promising management strategies, including specific drug therapies and contraindications.

Main Methods:

  • Literature review of epileptic encephalopathies.

Related Experiment Videos

  • Analysis of clinical characteristics and seizure types.
  • Summary of treatment approaches and drug considerations.

    • Main Results:

    • Epileptic encephalopathies present with varied seizure patterns and neurological decline.
    • Specific syndromes like SMEN, IS, LGS, and CSWS have distinct EEG and clinical features.
    • Promising treatments include clobazam/stiripentol for SMEN, vigabatrin for IS, lamotrigine for LGS, and steroids for CSWS.
    • Certain antiepileptic drugs (phenobarbital, phenytoin, carbamazepine, tiagabine, vigabatrin) can worsen outcomes and should be avoided.

    Conclusions:

    • Effective management of epileptic encephalopathies requires accurate diagnosis of specific syndromes.
    • Tailored treatment strategies are crucial, with specific drug recommendations for different conditions.
    • Awareness of potentially detrimental medications is vital for optimizing patient care and preventing neurological worsening.